Author:
Du Xiaomi,DeForest Natalie,Majithia Amit R.
Abstract
Non-alcoholic fatty liver disease (NAFLD) is a continuous progression of pathophysiologic stages that is challenging to diagnose due to its inherent heterogeneity and poor standardization across a wide variety of diagnostic measures. NAFLD is heritable, and several loci have been robustly associated with various stages of disease. In the past few years, larger genetic association studies using new methodology have identified novel genes associated with NAFLD, some of which have shown therapeutic promise. This mini-review provides an overview of the heterogeneity in NAFLD phenotypes and diagnostic methods, discusses genetic associations in relation to the specific stages for which they were identified, and offers a perspective on the design of future genetic mapping studies to accelerate therapeutic target identification.
Subject
Endocrinology, Diabetes and Metabolism
Reference116 articles.
1. Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes;Younossi;Hepatology,2016
2. Progression of NAFLD to Diabetes Mellitus, Cardiovascular Disease or Cirrhosis;Anstee;Nat Rev Gastroenterol Hepatol,2013
3. Global Epidemiology of NAFLD-Related HCC: Trends, Predictions, Risk Factors and Prevention;Huang;Nat Rev Gastroenterol Hepatol,2021
4. Trends in Liver Disease Etiology Among Adults Awaiting Liver Transplantation in the United States, 2014-2019;Wong;JAMA Netw Open,2020
5. The Diagnosis and Management of Nonalcoholic Fatty Liver Disease: Practice Guidance From the American Association for the Study of Liver Diseases;Chalasani;Hepatology,2018
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献